ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 55 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,857 | -15.3% | 36,466 | +44.8% | 0.00% | – |
Q2 2023 | $31,724 | +56.2% | 25,178 | -34.5% | 0.00% | -100.0% |
Q4 2022 | $20,309 | -36.5% | 38,428 | +1.0% | 0.00% | 0.0% |
Q3 2022 | $32,000 | +128.6% | 38,038 | +198.2% | 0.00% | – |
Q2 2022 | $14,000 | +7.7% | 12,755 | +2.3% | 0.00% | – |
Q4 2018 | $13,000 | – | 12,474 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 524,805 | $572,000 | 0.39% |
Laurion Capital Management LP | 2,225,800 | $2,426,000 | 0.04% |
Ergoteles LLC | 514,600 | $561,000 | 0.02% |
Pinz Capital Management, LP | 17,900 | $20,000 | 0.01% |
Alpine Global Management, LLC | 37,089 | $40,000 | 0.01% |
Game Plan Financial Advisors, LLC | 10,000 | $11,000 | 0.01% |
Spire Wealth Management | 100,300 | $109,000 | 0.00% |
Renaissance Technologies | 1,989,995 | $2,169,000 | 0.00% |
D. E. Shaw & Co., Inc. | 2,279,636 | $2,485,000 | 0.00% |
Y-Intercept (Hong Kong) Ltd | 16,912 | $18,000 | 0.00% |